Parexel, a provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, has announced it has completed the purchase of the Natural Language Processing (NLP) technology assets and transfer of key personnel of Roam Analytics, Inc., a healthcare software company based in San Francisco, California. This strengthens Parexel’s commitment to leveraging Artificial Intelligence and Machine Learning to drive new innovations across drug development and life sciences.
Roam Analytics’ technology platform enables organizations to leverage any source of healthcare language data, from clinical notes to patient surveys, regulatory documents, marketing materials, telemedicine interactions, social media and more, to aim to improve operational workflows.
Financial terms of the agreement were not disclosed.
Read the full release, here.
